Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 70,000 PLRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 70,000 | n/a |
| Mar 25, 2026 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 45,867 | n/a |
| Jan 9, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 40,000 | n/a |
| Jun 24, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 185,800 | n/a |
| Jun 10, 2025 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 30,000 | n/a |
| Apr 2, 2025 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 36,979 | $36.2K |
| Jun 18, 2024 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 26,764 | n/a |
| Mar 28, 2024 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 35,219 | n/a |
| Jun 8, 2023 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 14,000 | n/a |
| Mar 28, 2023 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 139,355 | n/a |